Last reviewed · How we verify
NCT05648903: Transform
The Transform Type 2 Diabetes Study
NA trial testing Total diet replacement in Type2diabetes in 120 participants. Status unknown.
30 July 2024
Quick facts
| Lead sponsor | Oviva UK Ltd |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 7 January 2022 |
| Primary completion | 30 July 2024 |
| Estimated completion | 30 July 2024 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Total diet replacement
- Low-carbohydrate diet
- Intermittent fasting 5:2
Conditions studied
- Type2diabetes — all drugs for Type2diabetes →
Sponsor
Oviva UK Ltd
Who can join
Adults 18 to 70, any sex, with Type2diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this mixed-methods, 12-month interventional study is to understand the effectiveness and acceptability of dietary interventions in type 2 diabetes mellitus (T2DM) in an ethnically diverse population. Three dietary interventions will be offered (total diet replacement, intermittent fasting and a low-carbohydrate diet) and two modes of remote care delivery will be used (group and one-to-one).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05648903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Total diet replacement
Trials testing the same drug.
- NCT05491005 — The eHealth Diabetes Remission Trial · NA · recruiting
Other recruiting trials for Type2diabetes
Currently open trials in the same condition.
- NCT06345196 — Motivational Interviewing Applied to Individuals With Diabetes · NA · recruiting
- NCT06322212 — Type 2 Diabetes and Blood Brain Barrier Improvement · EARLY_PHASE1 · recruiting
- NCT06575478 — Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients · Phase 2 · recruiting
- NCT06469437 — The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM · NA · recruiting
- NCT06875193 — DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes · Phase 4 · recruiting
Other Oviva UK Ltd trials
Trials by the same sponsor.
- NCT06119204 — SAFE-LCD Trial, for Insulin-treated Adults Living With Type 2 Diabetes · NA · terminated
- NCT05626842 — The DR-EAM Type 2 Diabetes Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05648903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oviva UK Ltd
- Last refreshed: 13 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05648903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing